增长激素会导致肌肉和脂肪的可逆纤维化:一项针对壮症患者的研究
Amanda Bæk1,2,3, Mai Christiansen Arlien-Søborg1,3,4, Anne Kathrine Nissen Pedersen2,3
1Department of Endocrinology and Internal Medicine, Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 165, 8200 Aarhus N, Denmark.
European journal of endocrinology
|February 17, 2026
概括
增长激素过量导致脂肪和肌肉组织的可逆纤维化. 控制GH过剩的治疗减少了这种纤维化,这表明直接的原形成效应而不是炎症.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 组织纤维化 组织纤维化
背景情况:
- 脂肪组织 (AT) 纤维化与肥胖和胰岛素抵抗有关.
- 由于生长激素 (GH) 过量而导致的巨,导致胰岛素耐药性,并刺激原蛋白合成.
- 壮症对组织纤维化的影响以前是未知的.
研究的目的:
- 量化原的循环和纤维化在脂肪和肌肉组织的壮病患者.
- 为了评估壮症治疗前后的变化.
主要方法:
- 在17名患者中分析了AT原蛋白含量和基因表达.
- 测量了15名患者的骨肌肉原蛋白含量和血清纤维细胞激活蛋白 (FAPα).
- 在两个队列中评估了原体周转生物标志物和炎症标志物.
主要成果:
- 在治疗后,AT原蛋白含量显著下降 (4.6%至2.1%).
- 在AT中,I型和III型原蛋白的基因表达分别下降了53%和39%.
- 肌肉原蛋白含量和FAPα活性/水平在疾病控制后也显著降低.
结论:
- 长时间的GH过量会导致人类脂肪和肌肉组织的可逆纤维化.
- 缩症中的纤维化似乎是由直接的原蛋白形成驱动的,而不是炎症.
- 这与在肥胖中观察到的纤维化机制形成鲜明对比.
更多相关视频
相关概念视频
Hypoglycemia and Glucagon
1.0K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
540
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540
Satellite Stem Cells and Muscular Dystrophy
2.4K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
Cross-bridge Cycle
123.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
123.1K
Major Hormones and Their Functions
2.1K
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
2.1K
Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K


